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We have recently found that primary rat embryonic ﬁbroblasts (REFs) could be immortalized by overexpression of the human
mitochondrial ribosomal protein MRPS18-2 (S18-2). A derived cell line, designated 18IM, expressed the embryonic stem cell
markers SSEA-1 and Sox2. Upon inoculation into severe combined immunodeﬁciency mice, 18IM cells differentiated to express
pan-keratin. They were not tumorigenic. Here we report the gene proﬁling of 18IM, compared with REF cells. Pathways involved
in oxidative phosphorylation, ubiquinone (Coenzyme Q 10) biosynthesis, fatty acid elongation in mitochondria, PI3K/AKT
signaling, a characteristic of rapidly proliferating cells, were upregulated in 18IM. Genes involved in the transcription/translation
machinery and redox reactions, like elongation factors, ATP synthases, NADH dehydrogenases, mitogen activated kinases were
upregulated as well. 18IM cells produced more pyruvate, indicating enhanced ATP synthesis. The expression of Oct4, Sox2, and
Nanog that can contribute to the experimental induction of pluripotency in primary ﬁbroblasts was also elevated, in contrast to
Klf4 and C-myc that were downregulated. Subsequently, three new immortalized cell lines were produced by S18-2
overexpression in order to check the representativeness of 18IM. All of them showed anchorage-independent growth pattern.
Two of three clones lost vimentin and smooth muscle actin, and expressed Sox2 and Oct4. We suggest that S18-2 is involved in
the developmental regulation.
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Mouse embryonic ﬁbroblasts have been converted into
pluripotent stem cells (iPSC) in vitro, by expressing four
genes, SOX2 (NM_003106), OCT4 (NM_002701), KLF4
(NM_004235), and C-MYC (NM_002467)
1–3 or, alterna-
tively, N-MYC (NM_005378).
4 Rat ﬁbroblasts could also
be turned into iPSC by the same four genes.
5 Human
primary ﬁbroblasts could be converted into stem cells by
the same or a slightly different set of genes, such as OCT4,
SOX2,NANOG(XM_002344645), andLIN28 (NM_024674).
6
Also, OCT4 and SOX2 could induce pluripotency in human
ﬁbroblasts by themselves, in conjunction with valproic acid,
a histone deacetylase inhibitor.
7 SOX2 and OCT4 could
generate iPSCs from cord blood cells without valproic
acid.
8,9
Wehaveaccidentallydiscoveredthatoverexpressionofthe
human mitochondrial ribosomal protein MRPS18-2 (S18-2,
NP_054765) immortalized primary rat embryonic ﬁbroblasts
(REFs).
10 The derived cell line, designated 18IM, lost its
sensitivity to contact inhibition and acquired the ability for
anchorage-independent growth in soft agar with a cloning
efﬁciency of 94%. It expressed the embryonic stem
cell markers SSEA-1 and Sox2 that were not detected in the
original REFs, nor in C-MYC- and HA-RAS-transformed
REFs. Moreover, the 18IM cells lost the expression of
mesodermal markers like vimentin and smooth muscle actin
(SMA). In contrast, they turned on the ectoderm- and
endoderm-speciﬁc pan-keratin, ectoderm-speciﬁc beta-III-
tubulin, and mesoderm-speciﬁc MHC class II markers in
conﬂuent culture. Part of the cells differentiated into Oil red
O stainable fat cells.
Upon subcutaneous inoculation into severe combined
immunodeﬁciency (SCID) mice, 18IM cells differentiated to
express pan-keratin. Unlike C-MYC and HA-RAS-trans-
formed ﬁbroblasts, they were not tumorigenic.
10
Here we report the gene expression pattern of 18IM cells
and three new S18-2-immortalized cell lines, in comparison
with control REFs.
Results
Stem cell marker expression in 18IM cells. The gene
expression proﬁle of 18IM cells was compared with REFs by
microarray techniques. Genes that showed a twofold and
higher difference with FDR-corrected P-value o0.05 were
selected for further studies.
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www.nature.com/cddisSupplementary Table S1 shows the differential gene
expression. More than 4000 differently expressed genes are
shown in an overview (Figure 1).
Ingenuity Pathway Analysis (IPA, Ingenuity Systems Inc.,
Redwood City, CA, USA) was performed for Gene ontology
studies on differential expression set (4209 genes). Several
canonical pathways, including ‘human embryonic stem cell
pluripotency’, the ‘NANOG pathway’, and others were
activated in 18IM cells (Table 1).
At least 19 cellular pathways were altered in the S18-2-
immortalized cells (Table 1). Upregulated genes include
COX and NDUF family genes, involved in proliferation,
oxidative phosphorylation, cellular respiration, and other
redox reactions, suggesting that 18IM cells are metabolically
more active. Their increased pyruvate release suggested an
elevated level of ATP production (Supplementary Figure S1),
in accordance with higher proliferation rate, as reported
earlier.
10
Genes involved in the WNT, BMP, and other self-renewal
pathways, like b-catenin (Ctnn-b), Bmpr3 (BMP receptor),
Smad1/5/8, Stat3, Spp1, Sox11, and Sh3glb1 were upregu-
lated. In contrast, genes involved in mesenchymal differentia-
tion, such as Runx2, Hoxc8, Creb, and Tlx2, or endoderm
development, as Foxd3, were downregulated. Essential
factors in the TGF-b and BMP pathways, like TGFFB3,
BMP1, BMP7, SMAD1, and CREB1 were also upregulated
with pathway expectation ( log (P-value)) of 1.64 and 1.19,
respectively. Many genes involved in the regulation of stem
cell development and proliferation were differently expressed
in 18IM and REF cells. Genes involved in the proliferation of
embryonic cells (30 genes), proliferation of neural stem cells
(9 genes), and survival of embryonic cells (11 genes) were
also differentially expressed.
Quantitative PCR validation of microarray data. Fifteen
genes that have an important role in stem cell phenotype
maintenance were chosen to validate the microarray data by
quantitative PCR (Q-PCR). The elongation factors Eef1A2
(NM_012660) and Tcea3 (NM_001015008) were strongly
upregulated in 18IM cells, in agreement with the micro-
array data (Figure 2). The expression of Eef1A2 increased
10000-fold (8933 according to microarray) and of Tcea3
increased by 393-fold (500 by microarray), suggesting
enhanced RNA synthesis. Gata3 (NM_133293) that may
be involved in histone acetylation
11 was overexpressed
(Figure 2, middle panel) while Gata4 (NM_144730) and
Gata6 (NM_019185), which are usually expressed
in differentiated tissues, were downregulated (Figure 2,
lowest panel). Genes inﬂuencing cell proliferation like
Tiam1 (NM_001100558), Epas1 (NM_023090), and Jmjd4
(NM_001105784) were expressed at a higher level in 18IM
cells. Similar changes were recorded by Q-PCR and
microarray for Tiam1 (566/106) and Jmjd4 (98/145).
18IM cells also showed a high expression of the testis-
speciﬁc Tssk1 gene (NM_001011900).
12 EST data showed
that this gene is expressed in the brain and in the germ
cell tumors. The placenta-speciﬁc Cdx2 gene (NM_023963)
was 100 times more highly expressed in 18IM, compared with
REF cells. Cdx2 expression was also reported in gastro-
intestinal and colorectal tumors, gliomas, and embryonic
tissue. Genes that participated in the experimental induction
of stem cell markers in normal ﬁbroblasts, such as Oct4,
Nanog, and Sox2 were also more highly expressed in 18IM
cells. However, C-myc and Klf4 were downregulated in the
immortalized cells.
There was no signiﬁcant change in the methylation status
of the promoter region of Oct-4, Sox2, Nanog, Lin28, and
C-myc in 18IM cells compared with REFs (see Supplemen-
tary Table S3), nor was there any difference in total genome
methylation (Supplementary Figure S2).
Protein expression. Protein expression was assayed by
western blotting and immunostaining. The immortalized 18IM
cells have lost vimentin and SMA expression, concomitantly
with the rise of Sox2, HIF1A, p53, RB, and p14ARF protein
levels, conﬁrming our previous data (Figure 3). Despite lower
levels of C-myc mRNA, C-myc protein was expressed at the
higher level in 18IM cells, compared with REFs, probably,
due to protein stabilization.
It is noteworthy that the embryonic stem cell marker
SSEA-1 was expressed on 30% of 18IM cells that have
grown in culture for 42 years (Supplementary Figure S2A).
Theywere non tumorigenic in SCID mice, after the inoculation
of 0.5–2 10
6 cells.
Experiments on newly generated S18-2-immortalized
REF lines. Three new S18-2-immortalized cell lines were
generated by transfecting REFs with GFP-S18-2 and pBabe-
S18-2 plasmids, followed by selection on G418. They were
followed in culture for 12 months. Clones 10 and 12 that
expressed GFP-S18-2 at a high level grew similarly to 18IM
cells, forming foci with a dense center, whereas clone 6 that
expressed a much lower level of S18-2 protein from a
pBabe construct did not form compact foci, but grew as a
monolayer, showing a high degree of cellular heterogeneity.
Clones 10 and 12 but not clone 6 showed anchorage-
independent growth (Figure 4). Cells (0.5 10
6) were
inoculated subcutaneously in SCID mice. After 2 months
no tumor formation was detected.
The protein expression pattern of the three new clones was
compared with 18IM and REF cells by western blotting. Clone
6 showed no loss of vimentin and SMA, in contrast to 18IM
Figure 1 Microarray data analysis of gene expression pattern in cells,
immortalizedbyoverexpressionofGFP-S18-2(18IM)comparedwithprimaryREFs.
In all, 4209 genes were expressed differently in 18IM-immortalized cells compared
with REFs
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Cell Death and DiseaseTable 1 Pathways that are regulated differently in 18IM cells compared with REFs
 2000-2009 Ingenuity Systems, Inc. all rights reserved. 
Ingenuity 
canonical 
pathways 
–Log 
(P-
value) 
Ratio Down 
regula 
ted 
No
change 
Up
regula
ted 
No 
overlap
with 
dataset 
Molecules* 
Oxidative 
phosphorylation 
5.15   1.33 e
–1 8/166 
(5%) 
0/166 
(0%) 
22/166 
(13%) 
136/166 
(82%) 
ATP6V0A4, COX7B, ATP6V1D, NDUFA10
(includes EG:4705), NDUFB5, COX7A2L,
NDUFB8, NDUFA1, COX6A2, ATP5J2,
ATP5F1, COX4I1, ATP5I, ATP5H (includes 
EG:641434),  COX4I2, ATP5O, ATP6V0A1,
NDUFA13, ATP6V1E1, COX8B, NDUFB11, 
NDUFV2, NDUFA11, NDUFA6, ATP5E,
COX2, SDHD, NDUFA3, NDUFB2, COX15
Mitochondrial 
dysfunction 
4.89 1.16  e
–1 8/172 
(5%) 
0/172 
(0%) 
20/172 
(12%) 
144/172 
(84%) 
 HSD17B10,  MAP2K4, COX7B, NDUFA10 
(includes EG:4705), NDUFB5, COX7A2L,
NDUFB8, COX6A2, SOD2, PARK7, GPX4, 
COX4I1, COX4I2, CASP3, MAPK9, GPX7, 
NDUFA13, COX8B, NDUFB11, NDUFV2, 
NDUFA11, NDUFA6, SDHD, COX2,
NDUFA3, SNCA, NDUFB2, COX15
Ubiquinone 
biosynthesis 
3.83 1.01  e
–1 3/119 
(3%) 
0/119 
(0%) 
12/119 
(10%) 
104/119 
(87%) 
 CYP7B1,  NDUFA10  (includes EG:4705), 
NDUFB5, METTL2B,  NDUFB8, METTL7B, 
NDUFA1, NDUFA13, NDUFB11, NDUFV2, 
NDUFA11, NDUFA6, NDUFA3, NDUFB2,
ALDH6A1
Butanoate 
metabolism 
2.58 7.52  e
–1 7/133 
(5%) 
0/133 
(0%) 
10/133 
(8%) 
116/133 
(87%) 
 HSD17B10,  ALDH1B1,  ECHS1,  NLGN1, 
ABAT, DCXR, PRDX6, PDHA1 (includes 
EG:29554), ALDH3A2, AUH, SDHD, OXCT1, 
MYO5B, HMGCL, HMGCS1, HADHA, 
ALDH7A1
Lysine 
degradation 
2.49 7.69  e
–1 8/234 
(3%) 
0/234 
(0%) 
18/234 
(8%) 
208/234 
(89%) 
  HSD17B10, SPCS3, LTA4H, RBP3, CTSD, 
CNDP2, CTSS, ALDH3A2, FAP, HADHA, 
BMP1, ALDH7A1, PLOD2, ALDH1B1, 
PAPPA, ECHS1, PSMB5, CASP3, 
PPP2R5C, PCSK7, REN, PREP, OGFOD2, 
AUH, SHMT2, GZMB
Valine, leucine 
and isoleucine 
degradation 
2.31 9.01  e
–1 9/111 
(8%) 
0/111 
(0%) 
10/111 
(9%) 
92/111 
(83%) 
  HSD17B10, ALDH1B1, ECHS1, ABAT, 
ACADSB, MUT, ACAD9, ACAA2, HIBCH, 
PCCA, ALDH3A2, AUH, OXCT1, HMGCL, 
IVD, HMGCS1, ALDH6A1, HADHA, 
ALDH7A1
Fatty acid 
elongation in 
mitochondria 
1.84 8.89  e
–2 2/45  (4%) 0/45  (0%) 4/45 
(9%) 
39/45 
(87%) 
 HSD17B10, ECHS1, MECR, AUH, ACAA2, 
HADHA
Agrin interactions 
at neuromuscular 
junction 
1.8 1.25  e
–1 9/72 
(13%) 
0/72 (0%) 9/72 
(13%) 
54/72 
(75%) 
MAP2K4, PXN, PAK2, NRAS, PAK6, RRAS, 
NRG1, LAMA2, DVL1, ITGA2, MAPK6,
ITGA6,  MAPK9, ITGA3, LAMC1, NRG3, 
LAMB1, CTTN
TGF-β signaling  1.64  1.16 e   12/86 
(14%) 
0/86 (0%) 10/86 
(12%) 
64/86 
(74%) 
MAP2K4, ZFYVE9, NRAS, FOXH1, RRAS, 
HOXC9, MAPK6, MAPK9, ACVR2B, INHBA, 
TLX2 (includes EG:3196), SMURF1, GSC, 
AMH, BMPR1A, MAP3K7, RUNX2, TGFB3, 
SMURF2, BMP7, HNF4A, SMAD1
Citrate cycle  1.52  8.47 e
–2 1/59  (2%) 0/59  (0%) 5/59 
(8%) 
53/59 
(90%) 
 IDH3G, SDHD, PCK1, FH, ACLY, ACO1
Synthesis and 
degradation of 
ketone bodies 
1.47 1.58  e
–1 1/19  (5%) 0/19  (0%) 3/19 
(16%) 
15/19 
(79%) 
 OXCT1, HMGCL, HMGCS1, HADHA
Chemokine 1.46  1.17  e
–1  6/77 (8%) 0/77 (0%) 9/77  62/77   CALML5, NRAS, CAMK1D, RRAS, CXCR4, 
–1
  , Q A N G   ) % 1 8 (   ) % 2 1 (   g n i l a n g i S MAPK6, PPP1CB, LIMK2, ROCK2, 
GNAI3,  MAPK14, CXCL12, CALM1, 
CAMK2B
Role of NANOG in 
mammalian 
embryonic Stem 
cell Pluripotency 
1.45 9.65  e
–2 11/114 
(10%) 
0/114 
(0%) 
11/114 
(10%) 
92/114 
(81%) 
  TP53, LIF, NRAS, WNT9B, RRAS, DVL1, 
MAPK6, STAT3, FOXD3, PIK3R3, GAB1, 
WNT10A, BMPR1A, PIK3CB, FZD5, BMP7,
CTNNB1, SMAD1, BMP8A, BMP1, WNT5A, 
IL11RA
BMP signaling 
pathway 
1.19 1  e
–1 13/80 
(16%) 
0/80 (0%) 8/80 
(10%) 
59/80 
(74%) 
MAP2K4, NRAS, RRAS, HOXC9, MAPK6,
PRKAR2A,  MAPK9, TLX2 (includes 
EG:3196), XIAP, SMURF1, MAPK14,
BMPR1A, RUNX2, MAP3K7, CREB1, 
PRKACA, PRKAG2, BMP7, SMAD1, 
BMP8A, BMP1
Human 
embryonic stem 
cell pluripotency 
9.51 
e
–1
6.94 e
–2 8/144 
(6%) 
0/144 
(0%) 
10/144 
(7%) 
126/144 
(88%) 
 S1PR2,  WNT9B,  BDNF,  FGFR1,  DVL1, 
FGFR2, PIK3R3, WNT10A, BMPR1A,
TGFB3,  BMP7, FZD5, PIK3CB, CTNNB1, 
SMAD1, BMP8A, BMP1, WNT5A
HIF1α signaling  9.49 
e
–1
8.57 e
–2 11/105 
(10%) 
0/105 
(0%) 
9/105 
(9%) 
85/105 
(81%) 
 TP53,  NRAS,  RRAS,  MMP14,  MAPK6,
MAPK9, MDM2, ARD1A, NOS3, P4HTM, 
PGF,  PIK3R3, VEGFA, TCEB2, MAPK14,
VEGFB (includes EG:89811), HSP90AA1, 
SPR, PIK3CB, APEX1
PI3K/AKT 
signaling 
3.19 
e
–1
5.15 e
–2 17/136 
(13%) 
0/136 
(0%) 
7/136 
(5%) 
112/136 
(82%) 
 TP53,  GAB2,  NRAS, PPP2R5C, BAD,
RRAS, ITGA2, MAPK6, MDM2, ITGA3, 
NOS3, EIF4EBP1, BCL2, PIK3R3, NFKBIA, 
FOXO1, GAB1, PPM1J, FOXO3, 
HSP90AA1, PPP2R2C, PIK3CB, PPP2R5E, 
CTNNB1
CXCR4 signaling  3.13 
e
–1
5.36 e
–2 23/168 
(14%) 
0/168 
(0%) 
9/168 
(5%) 
136/168 
(81%) 
 MAP2K4, GNB2L1, GNG13, GNA14, GNB1, 
ROCK2, PRKCE, GNA13, GNG4, PXN, 
NRAS, PAK2, PAK6, RRAS, CXCR4, 
MYLPF, GNAQ, MAPK6, MAPK9, GNG3, 
MYL6B, MYL7, PIK3R3, MYL9 (includes 
EG:10398), GNAI3, PRKCI, MYL12B, 
CXCL12, ITPR3, PIK3CB, PRKCH, GNAL
Sonic hedgehog 
signaling 
3 e
–1 6.45  e
–1 4/31 
(13%) 
0/31 (0%) 2/31 
(6%) 
25/31 
(81%) 
 GLI2, PRKAR2A, PRKACA, PRKAG2, GLI1,
CDC2
aUpregulated genes are indicated in bold. Magenta: ATP synthases, Blue: cytochrome C oxidases (or COX assembly proteins), Green: NADH dehydrogenases,
Pink: succinate–ubiquinone oxidoreductase, Red: mitogen-activated kinases (MAPK), Violet: bone morphogenetic proteins and BMP receptors
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Cell Death and Diseaseand clones 10 and 12 that expressed S18-2 at a high level
(Figure 5). Clones 10 and 12 expressed high levels of Oct4
andSox2,andabout5%ofthemexpressedSSEA-1. Onlythe
18IM cells (that were cultured for 12 months) expressed
E-cadherin.
Discussion
The MRPS18-2 (MRSPS18B, S18-2) protein is encoded by a
gene on human chromosome 6p21. 3, adjacent to the MHC
class II gene cluster. It was ﬁrst cloned from CD34þ
hematopoietic stem/progenitor cells by Zhang et al.
13 Simi-
larly to the other two members of the S18 family, S18-2 is
localized on the surface of the small subunit (28S) of the
mammalian mitochondrial ribosome.
14,15 We have previously
found that S18-2 is involved in the regulation of the RB
pathway. It binds to both hypo- and hyper-phosphorylated
retinoblastoma protein (RB) but not to other pocket proteins,
such as p107 and p130.
16 In EBV-transformed lympho-
blastoid cells a great portion of the normally cytoplasmic
S18-2 is targeted to the nucleus by one of the virally
encoded transforming proteins, EBNA-6.
17 Its binding to RB
displacesE2F1,leadingtoanincreaseoffreeE2F1.Thismay
presumably lift the RB-dependent block of S-phase entry;
Figure 2 Analysis of gene expression at the mRNA level in 18IM cells
compared with REFs by Q-PCR. Solid bars represent REFs, transparent bars
represent 18IM cells. Each bar shows the median value of 3–5 experiments
(performed in triplicates), normalized to TBP expression
Figure 3 Study of protein expression in 18IM cells compared with REFs by
western blotting. Membrane was probed with antibodies against vimentin, SOX-2,
C-MYC, HIF1A, SMA, p53, p14ARF, and retinoblastoma protein. Notice loss of
vimentin and SMA expression in 18IM cells
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Cell Death and Diseasea regular corollary of EBV-induced B-cell transformation.
It is noteworthy in this context that the S18-2 protein is mainly
localized in the nucleus in immortalized REFs.
10
We now report that numerous pathways, characteristic
for rapidly proliferating cells, are upregulated in 18IM. They
include genes involved in the transcription/translation
machinery, such as the elongation factors Eef1A2 and Tcea3,
and enzymes that participate in metabolic and redox
reactions, like the cytochrome C oxidases Cox4, Cox6A2,
Cox4I1-2, Cox8, and the NADH dehydrogenases NdufA3, 6,
11, 13, NdufB2 and 8 (Table 1). SOD2 (superoxide
dismutase), GPX4, and GPX7 (glutathione peroxidases)
genes were also upregulated in 18IM cells. Moreover, ATP
synthases (ATP5-E, F1, H, I, J2, and ATP50, ATP6-V0A1,
and ATP6-V1E1), usually located in the inner membrane of
the mitochondria, were also elevated in 18IM cells.
They also showed increased release of pyruvate (Supple-
mentary Figure S1) that may be associated with enhanced
ATP production.
The expression of Oct4, Sox2, and Nanog that have been
used for the experimental induction of PSC differentiation in
primary ﬁbroblasts was elevated in 18IM (Figure 2). Other
genes in the same experimental category,
5 such as Klf4 and
C-myc, were downregulated in 18IM cells. However, C-myc
protein was expressed at the higher level in immortalized
cells. It is noteworthy that 18IM cells was unable to produce
tumors in SCID mice, they transdifferentiated.
10 We may
speculate that C-myc protein was stabilized in immortalized
cells but its transactivating ability was inhibited.
As a step towards exploring the developmental role of the
S18-2 protein, we inhibited its expression in the Danio rerio
(Zebraﬁsh) model. Introduction of a S18-2-speciﬁc morpho-
linointotheﬁsheggsledtotheblockofS18-2translation.This
resulted in embryonic lethality (24–72h). Forty-eight hours
after the introduction of the morpholino into 308 eggs left no
living ﬁsh, in contrast to 488% of normally looking ﬁsh in the
control experiments. Simultaneous injection of morpholino
and in-vitro-transcribed S18-2 mRNA permitted the develop-
ment of normal ﬁsh. Further studies are in progress to explore
the developmental role of S18-2 in development in zebraﬁsh,
xenopus, and mouse models.
Figure 4 Growth pattern of clones produced from REFs that expressed S18-2 protein at different levels. Growth of clone 10 (a, GFP-S18-2) and clone 12 (b and c,
GFP-S18-2) in bacterial Petri dish. Notice embryoid-like body formation and proliferation of adherent cells. Growth of clone 6 (d–f), expressing S18-2 from pBabe construct,
in the ordinary ﬂask. Notice the heterogeneity of the cells, produced from one clone: smaller in the middle and larger at the periphery
Figure 5 Study of protein expression in the three recent clones, compared with
18IM cells and REFs, by western blotting. Notice that OCT4 and C-myc were
expressed at a higher level in clones 10, 12, and in 18IM cells. Clone 6 that
expressed S18-2 protein at a low level showed a decreased expression of SMA in
comparisonwithparentalREFs.18IMcellsexpressedE-cadherinthatwasabsentin
REFs, whereas the 3 clones did not
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Cell Death and DiseaseMaterials and Methods
Cellcultures. PrimaryREFsand18IMcellswereculturedatordinaryconditions
at 371C, using Iscove’s Modiﬁed Dulbecco’s Medium (IMDM) medium
supplemented by 10% of fetal bovine serum and appropriate antibiotics. 18IM
were cultured without feeder layer in IMDM that contained 0.5mg/ml of G418.
For microarray analysis 18IM cells were used that were propagated for more
than 1 year. Hoechst staining was used to monitor the absence of mycoplasma.
Microarray analysis. Total RNA was extracted from samples using the
RNeasy Mini kit (Qiagen Inc., Hilden, Germany), according to the manufacturer0s
recommendations. For each sample, 200ng total RNA was reverse transcribed,
linear ampliﬁed, and labeled with Cy3 using the one color Low RNA Input Linear
Ampliﬁcation Kit PLUS (Agilent Technologies, Santa Clara, CA, USA), according to
the manufacturer’s instructions and puriﬁed using the RNeasy Mini kit (Agilent
Technologies). After labeling, samples were measured on a Nanodrop microarray
module for labeling efﬁciency and quantiﬁcation. Samples were then hybridized on
Agilent 4 44K whole rat genome GE arrays (Agilent Design #014850) at 651C for
17h. After washing with GE washing buffer, the slide was scanned with Agilent
Microarray Scanner G2565BA (Agilent Technologies) at 5-mm resolution. Feature
extraction software (Version 9.5.3.1) was used to convert the image into gene
expression data. Data were normalized by the quantile method, using Partek. Only
genes with a false discovery rate r0.05 were selected as signiﬁcant with fold
change cutoff of 2. Molecular functions of genes were classiﬁed according to Gene
Ontology function using Ingenuity Pathway Analysis (IPA).
Methylation of gene promoter region in genomic DNA by direct sequencing after
sodium bisulﬁte treatment is described in Supplement (Materials and Methods
chapter).
Real-time PCR. Total RNA was isolated from REF and 18IM cells, using
RNeasy Mini kit (Qiagen Inc.). Approximately 1mg of total RNA was used for cDNA
synthesis, using First Strand Synthesis Kit (Sigma-Aldrich, St. Louis, MO, USA)
according to manufacturer’s protocol. cDNA obtained was used for Q-PCR studies.
Primer concentration was adjusted to a ﬁnal concentration of 3mM. Total reaction
volume for all real-time PCR experiments was 20ml. Real-timePCR was performed
using SYBR GREEN Master mix on 7900 machine (Applied Biosystems, Foster
City, CA, USA). The following primers for rat genes were used:
Cdx2 (Caudal type homeobox 2) For 50-CGTCCTGCGCCTCCGGATTG-30,
Rev 50-AGGGACGGCTGAGCTGGCTT-30; C-myc For 50-TCTCCGTCCTATGTT
GCGGTC-30, Rev 50-TCCAAGTAGCTCGGTCATCATCT-30; Eef1A2 (eukaryotic
translation elongation factor 1 alpha 2) For 50-CAAGGGCTGGAAGGTAGAGCG-30,
Rev 50-CCCAATGCCACCAATCTTGT-30; Epas1 (endothelial PAS domain protein 1
orHif2A)For5 0-CCCAAGAAGGTGACATGATCT-30,Rev5 0-CGCAGGGATGAGTGA
AGTCAAA-30; Gata-3 (GATA binding protein 3) For 50-CGAGGCCCAAGGCACGA
TCC-30, Rev 50-GCTCTCCTCGCTGCTGACAGC-30; Gata-4 For 50-GGAGCTGGC
CAGGACTGTCG-30, Rev 50-TGCGCAGGCCTTCGGATCAC-30; Gata-6 For 50-CG
GCCTGCCTTACCTGCAGG-30, Rev 50-GGCGAGTAGGGGAAGCGTGC-30; Jmjd4
(jumanji domain containing 4), For 50-AGCCTGGCGAGATGGTGTTTG-30, Rev
50-GCCATTGACCCAGTTGTGGT-30; Klf4 For 50-TTCTCCACGTTCGCGTCCGG-30,
Rev 50-TCTCGCCAACGGTTAGTCGGGG-30; Nanog For 50-TTGGAACGCTGC
TCCGCTCC-30, Rev 50-CGCCTGGCTTTCCCTAGTGGC-30; Oct4 For 50-GGAGG
GATGGCATACTGTGGACCT-30, Rev 50-TCCTGGGACTCCTCGGGACTAGG-30;
Sox2 For 50-ACTAATCACAACAATCGCGGCGGC-30, Rev 50-GACGGGCGAAGT
GCAATTGGGA-30; Tcea3 (transcription elongation factor A (SII), 3) For 50-GCTGA
ACAGTTGCCAGATGTC-30, Rev 50-GCAGCCGCTTCCAGTTTTTAAT-30; Tiam1
(T-cell lymphoma invasion and metastasis 1) For 50-TGCTGACATACGCCCCAAC
T-30; Rev 50-CAACAGTGGTTCTCAGCCCAA-30; Tssk1 (testis-speciﬁc serine
kinase) For 50-CCACCGCTCTATTGTCAAGAC-30, Rev 50-GCTCCTCTGGTTTTG
ATGAACT-30.
As an internal control for standardization, we have assayed the expression of a
gene encoding TATA-binding protein (Tbp, NM_003194). The following primers
wereused:For50-TTTCTTGCCAGTCTGGAC-30,Rev 50-CACGAACCACGGCACT
GATT-30.
The PCR cycling conditionswere the following:10min at 951C, 40 cycles of 10s
at 951C and 1min at 601C. Applied Biosystems7900 system softwarewas used for
analysis. Ct values were determined for the internal control (TBP) and the test
genes at the same threshold level in the exponential phase of the PCR curves.
Relative quantiﬁcation (comparative Ct (ddCt) method) was used to compare the
expression level of the test genes with the internal control. Dissociation curve
analysiswas performed after everyrun to checkthespeciﬁcityof thereaction. In all,
3–5 reactions (each in triplicates) were run for each gene and a standard deviation
was calculated.
Western blotting. Whole-cell lysates were prepared using NP40 lysis buffer
(1% NP40, 150mM NaCl, 50mM Tris, pH¼8) with a protease inhibitor cocktail
(Sigma-Aldrich). Lysates were cleared by centrifugation.
Proteins were separated by sodium SDS-polyacrylamide gel electrophoresis.
After transfer the membranes were probed with mouse antibodies against actin
(Sigma-Aldrich), SMA, vimentin, and p53 (DAKO, Glostrup, Denmark), C-MYC
(ABCAM Ltd, Cambridge, UK), RB (BD Pharmingen, San Diego, CA, USA), and
rabbit antibodies against OCT4 (Novus Biologicals, Littleton, CO, USA), SOX2
(ABCAMLtd),HIF1A,andE-cadherin(CellSignaling,Denver,MA,USA).Therabbit
polyclonal serum against p14ARF was the kind gift of Klas Wiman (CCK,
KI, Stockholm, Sweden). Secondary antibodies (anti-rabbit and anti-mouse IgG
Horseradish peroxidase-conjugated) were purchased from GE Healthcare
Bio-Sciences AB (Uppsala, Sweden).
Cell culture, immunostaining, imaging, and biochemical assays are described
in Supplement (Materials and Methods chapter).
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